- Home
- TSHA vs HRZN Comparison
TSHA vs HRZN Comparison
Compare TSHA & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- HRZN
- Stock Information
- Founded
- TSHA 2019
- HRZN 2008
- Country
- TSHA United States
- HRZN United States
- Employees
- TSHA N/A
- HRZN N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- HRZN Finance/Investors Services
- Sector
- TSHA Health Care
- HRZN Finance
- Exchange
- TSHA Nasdaq
- HRZN Nasdaq
- Market Cap
- TSHA 403.7M
- HRZN 396.1M
- IPO Year
- TSHA 2020
- HRZN 2010
- Fundamental
- Price
- TSHA $2.04
- HRZN $8.91
- Analyst Decision
- TSHA Strong Buy
- HRZN Sell
- Analyst Count
- TSHA 8
- HRZN 6
- Target Price
- TSHA $6.63
- HRZN $9.35
- AVG Volume (30 Days)
- TSHA 5.4M
- HRZN 467.6K
- Earning Date
- TSHA 11-13-2024
- HRZN 10-29-2024
- Dividend Yield
- TSHA N/A
- HRZN 15.08%
- EPS Growth
- TSHA N/A
- HRZN N/A
- EPS
- TSHA N/A
- HRZN N/A
- Revenue
- TSHA $9,915,000.00
- HRZN $104,553,000.00
- Revenue This Year
- TSHA N/A
- HRZN N/A
- Revenue Next Year
- TSHA N/A
- HRZN $7.48
- P/E Ratio
- TSHA N/A
- HRZN N/A
- Revenue Growth
- TSHA N/A
- HRZN N/A
- 52 Week Low
- TSHA $1.19
- HRZN $8.46
- 52 Week High
- TSHA $4.32
- HRZN $13.73
- Technical
- Relative Strength Index (RSI)
- TSHA 42.15
- HRZN 36.70
- Support Level
- TSHA $1.97
- HRZN $8.46
- Resistance Level
- TSHA $2.72
- HRZN $9.44
- Average True Range (ATR)
- TSHA 0.24
- HRZN 0.17
- MACD
- TSHA -0.10
- HRZN -0.03
- Stochastic Oscillator
- TSHA 4.48
- HRZN 45.45
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services and sustainability industries.